280 related articles for article (PubMed ID: 25397625)
1. Phantom studies and clinical application of high resolution, image reconstruction using (18)F-fluoromethylcholine PET/CT for prostate cancer.
Zielinski A; Behrendt FF; Verburg FA; Mottaghy FM; Krohn T
Hell J Nucl Med; 2014; 17(3):194-9. PubMed ID: 25397625
[TBL] [Abstract][Full Text] [Related]
2. Improving the detection of small lesions using a state-of-the-art time-of-flight PET/CT system and small-voxel reconstructions.
Koopman D; van Dalen JA; Lagerweij MC; Arkies H; de Boer J; Oostdijk AH; Slump CH; Jager PL
J Nucl Med Technol; 2015 Mar; 43(1):21-7. PubMed ID: 25613334
[TBL] [Abstract][Full Text] [Related]
3. No clinically relevant differences between positron emission tomography (PET) reconstructions based on low-dose or contrast-enhanced CT in combined integrated multiphase (18) F-Fluorethylcholine PET/CT for prostate cancer.
Behrendt FF; Lensing C; Keil S; Mottaghy FM; Verburg FA
J Med Imaging Radiat Oncol; 2016 Aug; 60(4):498-505. PubMed ID: 27297449
[TBL] [Abstract][Full Text] [Related]
4. 18F-fluoride PET/CT for bone scanning. Role of attenuation correction.
Nagarajah J; Dannat T; Hartung V; Bockisch A; Rosenbaum-Krumme S
Nuklearmedizin; 2012; 51(3):84-7. PubMed ID: 22366817
[TBL] [Abstract][Full Text] [Related]
5. Detection and localization of prostate cancer: correlation of (11)C-choline PET/CT with histopathologic step-section analysis.
Farsad M; Schiavina R; Castellucci P; Nanni C; Corti B; Martorana G; Canini R; Grigioni W; Boschi S; Marengo M; Pettinato C; Salizzoni E; Monetti N; Franchi R; Fanti S
J Nucl Med; 2005 Oct; 46(10):1642-9. PubMed ID: 16204714
[TBL] [Abstract][Full Text] [Related]
6. [Pitfalls with 18F-choline PET/CT in patients with prostate cancer].
García Vicente AM; Núñez García A; Soriano Castrejón AM; Jiménez Londoño GA; Cordero García JM; Palomar Muñoz A
Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):37-9. PubMed ID: 23177342
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer: 1HMRS-DCEMR at 3T versus [(18)F]choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after radical retropubic prostatectomy (RRP).
Panebianco V; Sciarra A; Lisi D; Galati F; Buonocore V; Catalano C; Gentile V; Laghi A; Passariello R
Eur J Radiol; 2012 Apr; 81(4):700-8. PubMed ID: 21330082
[TBL] [Abstract][Full Text] [Related]
8. Improvement in clinical evaluation of PET/CT images with high resolution algorithms.
Orlandini LC; Betti M; Fulcheri C; Dona M; Fisicaro D; Castagnoli A
Q J Nucl Med Mol Imaging; 2013 Jun; 57(2):201-6. PubMed ID: 23486348
[TBL] [Abstract][Full Text] [Related]
9. Whole-body 18F-FDG PET/CT in the presence of truncation artifacts.
Beyer T; Bockisch A; Kühl H; Martinez MJ
J Nucl Med; 2006 Jan; 47(1):91-9. PubMed ID: 16391192
[TBL] [Abstract][Full Text] [Related]
10. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
[TBL] [Abstract][Full Text] [Related]
11. [(11)C]Choline positron emission tomography/computed tomography for staging and restaging of patients with advanced prostate cancer.
Tuncel M; Souvatzoglou M; Herrmann K; Stollfuss J; Schuster T; Weirich G; Wester HJ; Schwaiger M; Krause BJ
Nucl Med Biol; 2008 Aug; 35(6):689-95. PubMed ID: 18678354
[TBL] [Abstract][Full Text] [Related]
12. Phantom and Clinical Evaluation of the Bayesian Penalized Likelihood Reconstruction Algorithm Q.Clear on an LYSO PET/CT System.
Teoh EJ; McGowan DR; Macpherson RE; Bradley KM; Gleeson FV
J Nucl Med; 2015 Sep; 56(9):1447-52. PubMed ID: 26159585
[TBL] [Abstract][Full Text] [Related]
13. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
[TBL] [Abstract][Full Text] [Related]
14. Interpolated average CT for attenuation correction in PET--a simulation study.
Mok GS; Sun T; Huang TC; Vai MI
IEEE Trans Biomed Eng; 2013 Jul; 60(7):1927-34. PubMed ID: 23392338
[TBL] [Abstract][Full Text] [Related]
15. A dual modality approach to quantitative quality control in emission tomography.
Thomas MD; Bailey DL; Livieratos L
Phys Med Biol; 2005 Aug; 50(15):N187-94. PubMed ID: 16030376
[TBL] [Abstract][Full Text] [Related]
16. Multimodal Partial-Volume Correction: Application to 18F-Fluoride PET/CT Bone Metastases Studies.
Grecchi E; O'Doherty J; Veronese M; Tsoumpas C; Cook GJ; Turkheimer FE
J Nucl Med; 2015 Sep; 56(9):1408-14. PubMed ID: 26182970
[TBL] [Abstract][Full Text] [Related]
17. C-11 choline PET/CT imaging for differentiating malignant from benign prostate lesions.
Li X; Liu Q; Wang M; Jin X; Liu Q; Yao S; Liu S; Li J
Clin Nucl Med; 2008 Oct; 33(10):671-6. PubMed ID: 18806565
[TBL] [Abstract][Full Text] [Related]
18. Value of 11C-choline PET and PET/CT in patients with suspected prostate cancer.
Scher B; Seitz M; Albinger W; Tiling R; Scherr M; Becker HC; Souvatzogluou M; Gildehaus FJ; Wester HJ; Dresel S
Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):45-53. PubMed ID: 16932935
[TBL] [Abstract][Full Text] [Related]
19. Clinical evaluation of PET image reconstruction using a spatial resolution model.
Andersen FL; Klausen TL; Loft A; Beyer T; Holm S
Eur J Radiol; 2013 May; 82(5):862-9. PubMed ID: 23254158
[TBL] [Abstract][Full Text] [Related]
20. Deep Inspiration Breath Hold [(18)F]FDG PET-CT on 4-rings scanners in evaluating lung lesions: evidences from a phantom and a clinical study.
Caobelli F; Puta E; Kaiser SR; Massetti V; Andreoli M; Mostarda A; Soffientini A; Pizzocaro C; Guerra UP
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):136-47. PubMed ID: 24268841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]